Low-dose iron chelation as anti-oxidative therapy in patients with sickle cell disease: A single-centre pilot study

Br J Haematol. 2024 Dec 6. doi: 10.1111/bjh.19943. Online ahead of print.

Aafke E Gaartman^{1

2}, Boukje M Beuger², Lydian A de Ligt^{1

2

3}, Martijn Veldthuis⁴, Hanke L Matlung^{2

4}, Joost C M Meijers^{2

5}, Casper G Schalkwijk⁶, Koen de Heer^{1

7}, Jarom Heijmans¹, Rob van Zwieten⁴, Bart J Biemond¹, Robin van Bruggen², Erfan Nur^{1

2}

¹ Department of Hematology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
² Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands.
³ Department of Pediatric Hematology, Emma Children's Hospital, AUMC, University of Amsterdam, Amsterdam, The Netherlands.
⁴ Sanquin Diagnostics, Laboratory of Red Blood Cell Diagnostics and Iron, Amsterdam, The Netherlands.
⁵ Department of Experimental Vascular Medicine, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
⁶ Department of Internal Medicine, School for Cardiovascular Diseases (CARIM), Maastricht University Medical Center, Maastricht, The Netherlands.
⁷ Department of Internal Medicine, Flevoziekenhuis, Almere, The Netherlands.

No abstract available

Publication types